Literature DB >> 16563503

Mantle cell lymphoma-derived cell lines: unique research tools.

Hans G Drexler, Roderick A F MacLeod.   

Abstract

Mesh：

Year:  2006        PMID： 16563503     DOI： 10.1016/j.leukres.2006.02.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  5 in total

Review 1.  Cell line misidentification: the beginning of the end.

Authors: 
Journal:  Nat Rev Cancer       Date:  2010-05-07       Impact factor: 60.716

2.  Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

Authors:  Lapo Alinari; Bo Yu; Beth A Christian; Fengting Yan; Jungook Shin; Rosa Lapalombella; Erin Hertlein; Mark E Lustberg; Carl Quinion; Xiaoli Zhang; Gerard Lozanski; Natarajan Muthusamy; Mette Prætorius-Ibba; Owen A O'Connor; David M Goldenberg; John C Byrd; Kristie A Blum; Robert A Baiocchi
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

3.  FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Authors:  Lapo Alinari; Emilia Mahoney; John Patton; Xiaoli Zhang; Lenguyen Huynh; Christian T Earl; Rajeswaran Mani; Yicheng Mao; Bo Yu; Carl Quinion; William H Towns; Ching-Shih Chen; David M Goldenberg; Kristie A Blum; John C Byrd; Natarajan Muthusamy; Mette Praetorius-Ibba; Robert A Baiocchi
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

4.  Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.

Authors:  Robert S Boyd; Rebekah Jukes-Jones; Renata Walewska; David Brown; Martin J S Dyer; Kelvin Cain
Journal:  Mol Cell Proteomics       Date:  2009-04-02       Impact factor: 5.911

5.  Prevalence and characterization of murine leukemia virus contamination in human cell lines.

Authors:  Cord C Uphoff; Sandra Lange; Sabine A Denkmann; Henk S P Garritsen; Hans G Drexler
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.